Group items matching

in title, tags, annotations or url

The pharmacy chain has already announced plans to permanently close hundreds of its branches across the UK to consolidate its portfolio of 2,200 stores to 1,900. Two of its branches in North Wales will be closed next year, with its site in Rhos on Sea set to close its doors in March 2024 and the shop in Colywn Bay the following month. In a statement obtained by The Sun, Clwyd West MP David Jones has branded the closures "hugely bad news for the local community". He added that it is not "a case of simple shop closures," but "another body blow for the local retail economy." The Station Road shopping centre, where the Colwyn Bay store is located, has already seen the closure of several other prominent stores, including WHSmith, the MP stated. The closure of two Boots stores will leave many people "extremely worried as to how they will be able to obtain essential medicines," he added.

The Department of Health and Social Care (DHSC) has published the full text of the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The 2024 VPAG agreement text sets out the detailed terms of the agreement reached between DHSC, NHS England and the Association of the British Pharmaceutical Industry (ABPI) to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector. The new voluntary scheme will come into force on 1 January 2024, following expiry of the 2019 Voluntary Scheme and shall remain in force for a period of five years, until 31 December 2028. Manufacturers or suppliers of branded medicines to the NHS have been given time till 15 January 2024 to decide whether to join the new 2024 Voluntary Scheme, or default to the updated Statutory Scheme.

Poverty not only takes a significant toll on people's health but also leads to additional costs for the National Health Service (NHS). Rise in deep poverty, cost-of-living crisis, and high pressure on NHS services have worsened the situation, according to a study published by The King's Fund this week. The report underscored that poverty and deprivation contribute to a greater prevalence of diseases, difficulties in accessing health care, late or delayed treatment, and worse health outcomes. These challenges could be seen across various NHS services, spanning from emergency care to dental services Additionally, it revealed that 30 per cent of people living in the most deprived areas have turned to 999, 111, A&E or a walk-in centre because they could not access a GP appointment. In 2016, the Joseph Rowntree Foundation (JRF) estimated the cost of poverty on health care at £29 billion (£34 billion in current prices). As the proportion of people living in deep poverty has risen, the situation has worsened. In 2021/22, six million people were living in very deep poverty, up from 4.5 million two decades ago. Currently, more than one in five people in the UK are estimated to be living in poverty, the report noted. Deprivation is linked to a range of diet-related health problems, including cardiovascular disease and diabetes, as well as mental illness. According to the report, the depression rate is two times higher among people living in the most deprived areas, compared to the least deprived areas.

Dr. Boon Lim is the voted best cardiologist in London. He provides personalized patient care, tailored to your needs. Dr. Lim is able to see you at several locations for your convenience, where you can expect to receive world-class care. Consultation starts with a history and thorough understanding of your needs and often fears, and his empathetic style, and clear decision-making, underscored by expert knowledge in his field, give patients the assurance and confidence that they are receiving an exceptional healthcare experience entirely focussed on the patient's concerns.

The Market Research on Wound Debridement, By Considering useful aspects like; Material, Product, Application, End User (Hospital, ASCs) - Global Future Forecast till 2023, published by MarketsandMarkets™, the report studies the global Wound Debridement market over the forecast period of 2017 to 2023. The market is projected to reach USD 1,041.0 Million by 2023 at a CAGR of 8.2%.

The Centre for Pharmacy Postgraduate Education (CPPE) has announced launch of the new e-learning programme on controlled drugs in chronic pain to support patients. The programme launched on Monday (January 17), aims to support pharmacy professionals to develop the knowledge, skills and behaviours to support patients to use prescribed controlled drugs safely with a focus on chronic pain. The new programme will open new opportunities for pharmacy professionals to improve patient care, in relation to the safe prescribing and use of controlled drugs.

The life cycle management company, Pharmanovia, has appointed Nivedita Valentine as associate vice president of Product Innovation. Ms Valentine will oversee the company's product innovation operations and decision-making as Pharmanovia continues to focus efforts on both, identifying new prospects to enhance lifecycle management of its brands through incremental innovation. She will report to interim chief scientific officer Stephen Deacon and help bridge unmet patient needs with the help of novel therapies, originating both from in-house development and through partnerships. Ms Valentine currently holds positions on the value-added medicines committee within Medicines for Europe and the International Rare Diseases Research Consortium (IRDiRC) Task Force on Drug Repurposing Guidebook. Pharmanovia CEO Dr James Burt commented: "Digitalisation and utilising the latest technological innovation are notable areas of acceleration within the pharma industry and Nivedita's appointment will ensure iconic brands will continue to be improved, supported, and used sustainably.

Community pharmacies in England will continue to receive the free protective equipment (PPE) as the Government's scheme has been extended for another year until March 2024. The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social care staff according to demand until the end of March 2024, or when stocks run out. Last year, DHSC implemented a new and improved portal platform for eligible providers to access free COVID-19 related PPE supplies. The Pharmaceutical Services Negotiating Commitee (PSNC) said: "Community pharmacy teams can continue to order PPE from the NHS PPE portal for free for as long as stock is available."

The nationwide implementation of the Pharmacy First service is viewed as a significant development that benefits pharmacies, primary care, and the broader National Health Service (NHS). Pharmacy teams are striving to ensure its success despite challenges within the industry landscape. However, not all pharmacists are able to reap the benefits from it. Recently, two members of Numark shared their experiences of how the scheme is impacting their pharmacies. Graham Phillips, who owns Letchworth Pharmacy in Hertfordshire, revealed that patients are responding favourably to the service. "It's all good, people are just delighted to have easier access to care," he said. In its first month, Letchworth Pharmacy provided around 100 consultations, and Phillips envisions that as the service matures, they will be able to conduct an average of 200 interventions per week. "That will make it financially viable for us and mean that we're acting at scale from an NHS perspective. That's 200 GP appointments we've freed up in a week - that's a huge capability and capacity bump for the NHS," he added. Graham credits part of his success with Pharmacy First to the strong relationship he has established with local GPs in his area.